Does Erythropoietin Promote Tumor Growth?

In Response: We appreciate Yoon and colleagues' interest in our report and welcome the opportunity to reply to their comments. Our study was designed in a context in which several clinical trials, including patients with head and neck squamous cell carcinomas, breast cancer, non–small cell lung

[1]  A. Sytkowski,et al.  Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells , 2008, International journal of cancer.

[2]  M. Suntharalingam,et al.  Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). , 2007, International journal of radiation oncology, biology, physics.

[3]  M. Kampa,et al.  Erythropoietin and Its Receptor in Breast Cancer: Correlation with Steroid Receptors and Outcome , 2007, Cancer Epidemiology Biomarkers & Prevention.

[4]  M. Karamouzis,et al.  Selective modulation of the erythropoietic and tissue-protective effects of erythropoietin: time to reach the full therapeutic potential of erythropoietin. , 2007, Biochimica et biophysica acta.

[5]  P. Validire,et al.  Erythropoietin and Erythropoietin Receptor Coexpression Is Associated with Poor Survival in Stage I Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.

[6]  A. Sytkowski.  Does Erythropoietin Have a Dark Side? Epo Signaling and Cancer Cells , 2007, Science's STKE.

[7]  M. Dewhirst,et al.  Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression , 2007, PloS one.

[8]  S. Perrotta,et al.  Erythropoietin receptors on cancer cells: a still open question. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  N. Agarwal,et al.  Are erythropoietin receptors expressed in tumors? Facts and fiction--more careful studies are needed. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Wilson Roa,et al.  Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Cerami,et al.  Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia , 2006, Proceedings of the National Academy of Sciences.

[12]  S. Mukherjee,et al.  A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.

[13]  A. Verma,et al.  Erythropoietin receptors on cancer cells: exciting perspectives, difficult to appreciate. , 2006, Blood.

[14]  G. Schwarzer,et al.  Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. , 2006, Journal of the National Cancer Institute.

[15]  C. Begley,et al.  Anti-Epo receptor antibodies do not predict Epo receptor expression. , 2006, Blood.

[16]  J. Baselga,et al.  Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Dalgard,et al.  Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. , 2005, Neoplasia.

[18]  D. Elder,et al.  Functional erythropoietin autocrine loop in melanoma. , 2005, The American journal of pathology.

[19]  M. Bernaudin,et al.  Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  M. Tada,et al.  Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer. , 2004, The Journal of surgical research.

[21]  C. Rübe,et al.  Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial , 2003, The Lancet.

[22]  G. Acs,et al.  Erythropoietin and erythropoietin receptor expression in human cancer. , 2001, Cancer research.